These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


479 related items for PubMed ID: 8070360

  • 21. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A, Nappi RE, Polatti F, Poma A, Grossman AB, Nappi G.
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [Abstract] [Full Text] [Related]

  • 22. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

  • 23. Hypothalamic oxytocin in the developing ovine fetus: interaction with pituitary-adrenocortical function.
    Matthews SG.
    Brain Res; 1999 Feb 27; 820(1-2):92-100. PubMed ID: 10023035
    [Abstract] [Full Text] [Related]

  • 24. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
    Dakine N, Oliver C, Grino M.
    J Neuroendocrinol; 2000 Aug 27; 12(8):774-83. PubMed ID: 10929090
    [Abstract] [Full Text] [Related]

  • 25. Acute Mono-Arthritis Activates the Neurohypophysial System and Hypothalamo-Pituitary Adrenal Axis in Rats.
    Nishimura H, Kawasaki M, Matsuura T, Suzuki H, Motojima Y, Baba K, Ohnishi H, Yamanaka Y, Fujitani T, Yoshimura M, Maruyama T, Ueno H, Sonoda S, Nishimura K, Tanaka K, Sanada K, Onaka T, Ueta Y, Sakai A.
    Front Endocrinol (Lausanne); 2020 Aug 27; 11():43. PubMed ID: 32117068
    [Abstract] [Full Text] [Related]

  • 26. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S, Smith MA, Gold PW.
    Endocrinology; 1995 Aug 27; 136(8):3299-309. PubMed ID: 7628364
    [Abstract] [Full Text] [Related]

  • 27. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
    Al-Barazanji KA, Wilson S, Baker J, Jessop DS, Harbuz MS.
    J Neuroendocrinol; 2001 May 27; 13(5):421-4. PubMed ID: 11328451
    [Abstract] [Full Text] [Related]

  • 28. Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice.
    Téblick A, De Bruyn L, Van Oudenhove T, Vander Perre S, Pauwels L, Derde S, Langouche L, Van den Berghe G.
    Endocrinology; 2022 Jan 01; 163(1):. PubMed ID: 34698826
    [Abstract] [Full Text] [Related]

  • 29. Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat.
    Takemura T, Makino S, Takao T, Asaba K, Suemaru S, Hashimoto K.
    Brain Res; 1997 Sep 05; 767(2):181-91. PubMed ID: 9367246
    [Abstract] [Full Text] [Related]

  • 30. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V, Winterhoff H, Herkenham M.
    Mol Psychiatry; 2001 Sep 05; 6(5):547-64. PubMed ID: 11526469
    [Abstract] [Full Text] [Related]

  • 31. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y, Spangler R, Schlussman SD, Ho A, Kreek MJ.
    Brain Res; 2003 Feb 28; 964(2):187-99. PubMed ID: 12576179
    [Abstract] [Full Text] [Related]

  • 32. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
    Zelena D, Mergl Z, Makara GB.
    Brain Res; 2005 Jan 21; 1031(2):185-93. PubMed ID: 15649443
    [Abstract] [Full Text] [Related]

  • 33. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM, Vaughan JM, Donaldson CJ, Rivier J, Li C, Chen A, Vale WW.
    Endocrinology; 2004 Nov 21; 145(11):5202-9. PubMed ID: 15271883
    [Abstract] [Full Text] [Related]

  • 34. The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey.
    Shridhar S, Farley A, Reid RL, Foster WG, Van Vugt DA.
    Toxicol Sci; 2001 Oct 21; 63(2):181-8. PubMed ID: 11568361
    [Abstract] [Full Text] [Related]

  • 35. Corticotropin-releasing hormone and arginine vasopressin gene transcription in the hypothalamic paraventricular nucleus of unstressed rats: daily rhythms and their interactions with corticosterone.
    Watts AG, Tanimura S, Sanchez-Watts G.
    Endocrinology; 2004 Feb 21; 145(2):529-40. PubMed ID: 14563696
    [Abstract] [Full Text] [Related]

  • 36. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G, Ixart G, Tapia-Arancibia L, Givalois L.
    Neuroscience; 2006 May 12; 139(2):779-89. PubMed ID: 16457953
    [Abstract] [Full Text] [Related]

  • 37. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
    Maruyama H, Makino S, Noguchi T, Nishioka T, Hashimoto K.
    Neuroendocrinology; 2007 May 12; 86(1):1-16. PubMed ID: 17551262
    [Abstract] [Full Text] [Related]

  • 38. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats.
    Itoi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abe K, Demura H.
    Endocrinology; 1994 Nov 12; 135(5):2177-82. PubMed ID: 7956940
    [Abstract] [Full Text] [Related]

  • 39. Arginine vasopressin (AVP) depletion in neurons of the suprachiasmatic nuclei affects the AVP content of the paraventricular neurons and stimulates adrenocorticotrophic hormone release.
    Gomez F, Chapleur M, Fernette B, Burlet C, Nicolas JP, Burlet A.
    J Neurosci Res; 1997 Nov 15; 50(4):565-74. PubMed ID: 9404718
    [Abstract] [Full Text] [Related]

  • 40. Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat.
    Dakine N, Oliver C, Grino M.
    Life Sci; 2000 Oct 27; 67(23):2827-44. PubMed ID: 11105998
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.